Prognostic Value of MRD Detection in CA125 Non-sensitive Ovarian Cancer Patients

NCT06182917 · clinicaltrials.gov ↗
RECRUITING
Status
35
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

West China Second University Hospital